Key result
Orthostatic hypotension affects ~12% of US adults and is linked to increased mortality and recurrent falls.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May guide tailored management of neurogenic orthostatic hypotension; leaves open prospective validation of pathways.
Key Points
- To synthesize the underlying mechanisms, clinical diagnostic criteria, and evidence-based management strategies for neurogenic orthostatic hypotension.
- Reviewed clinical features and autonomic testing protocols used to distinguish neurogenic orthostatic hypotension from non-neurogenic causes.
- Evaluated pharmacologic and nonpharmacologic interventions aimed at restoring standing blood pressure and minimizing symptoms.
- Autonomic nervous system impairment disrupts norepinephrine release from postganglionic sympathetic neurons, causing persistent blood pressure drops upon standing.
- Effective clinical care integrates nonpharmacologic volume expansion with targeted pharmacotherapy, including midodrine, droxidopa, and fludrocortisone.
PICO
P
Population
Orthostatic hypotension
Orthostatic hypotension is a common condition, particularly in the elderly, that presents significant clinical challenges due to its association with falls, morbidity, and concurrent supine hypertension.
Cite This Study
Goldstein et al. (2009) conducted a review in Orthostatic hypotension. Orthostatic hypotension has a prevalence of approximately 12% in the United States and is associated with increased mortality, recurrent falls, and supine hypertension.